BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26074140)

  • 1. The corrected donor age for hepatitis C virus-infected liver transplant recipients.
    Dirchwolf M; Dodge JL; Gralla J; Bambha KM; Nydam T; Hung KW; Rosen HR; Feng S; Terrault NA; Biggins SW
    Liver Transpl; 2015 Aug; 21(8):1022-30. PubMed ID: 26074140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor Risk Index for African American liver transplant recipients with hepatitis C virus.
    Shores NJ; Dodge JL; Feng S; Terrault NA
    Hepatology; 2013 Oct; 58(4):1263-9. PubMed ID: 23696235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term Outcomes After Liver Transplantation Among Human Immunodeficiency Virus-Infected Recipients.
    Locke JE; Durand C; Reed RD; MacLennan PA; Mehta S; Massie A; Nellore A; DuBay D; Segev DL
    Transplantation; 2016 Jan; 100(1):141-6. PubMed ID: 26177090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplant recipients and prioritization of anti-HCV therapy: an Italian cohort analysis.
    Lanini S; Nanni Costa A; Grossi PA; Procaccio F; Ricci A; Capobianchi MR; Terrault NA; Ippolito G
    Liver Int; 2016 Mar; 36(3):410-7. PubMed ID: 26264452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.
    Hung K; Gralla J; Dodge JL; Bambha KM; Dirchwolf M; Rosen HR; Biggins SW
    Liver Transpl; 2015 Nov; 21(11):1365-73. PubMed ID: 25865434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimizing Risk Associated With Older Liver Donors by Matching to Preferred Recipients: A National Registry and Validation Study.
    Haugen CE; Thomas AG; Garonzik-Wang J; Massie AB; Segev DL
    Transplantation; 2018 Sep; 102(9):1514-1519. PubMed ID: 29570165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longterm results of liver transplantation from donation after circulatory death.
    Blok JJ; Detry O; Putter H; Rogiers X; Porte RJ; van Hoek B; Pirenne J; Metselaar HJ; Lerut JP; Ysebaert DK; Lucidi V; Troisi RI; Samuel U; den Dulk AC; Ringers J; Braat AE;
    Liver Transpl; 2016 Aug; 22(8):1107-14. PubMed ID: 27028896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of the low-accelerating-dose regimen in 182 liver recipients with recurrent hepatitis C virus.
    Lim KB; Sima HR; Fiel MI; Khaitova V; Doucette JT; Chernyiak M; Ahmad J; Bach N; Chang C; Grewal P; Kim-Schluger L; Liu L; Odin J; Perumalswami P; Florman SS; Schiano TD
    World J Gastroenterol; 2015 May; 21(20):6236-45. PubMed ID: 26034358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of donor race on the survival of Black Americans undergoing liver transplantation for chronic hepatitis C.
    Pang PS; Kamal A; Glenn JS
    Liver Transpl; 2009 Sep; 15(9):1126-32. PubMed ID: 19718638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplantation from anti-hepatitis C virus-positive donors: our experience.
    Álvaro E; Abradelo M; Fuertes A; Manrique A; Colina F; Alegre C; Calvo J; García M; García-Sesma A; Cambra F; Sanabria R; Moreno E; Jimenez C
    Transplant Proc; 2012; 44(6):1475-8. PubMed ID: 22841188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The UK DCD Risk Score: A new proposal to define futility in donation-after-circulatory-death liver transplantation.
    Schlegel A; Kalisvaart M; Scalera I; Laing RW; Mergental H; Mirza DF; Perera T; Isaac J; Dutkowski P; Muiesan P
    J Hepatol; 2018 Mar; 68(3):456-464. PubMed ID: 29155020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor hypernatremia before procurement and early outcomes following pediatric liver transplantation.
    Kaseje N; McLin V; Toso C; Poncet A; Wildhaber BE
    Liver Transpl; 2015 Aug; 21(8):1076-81. PubMed ID: 25902852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor diabetes mellitus is an independent risk factor for graft loss in HCV positive but not HCV negative liver transplant recipients.
    Wu Y; Ahmed A; Kamal A
    Dig Dis Sci; 2013 Feb; 58(2):574-8. PubMed ID: 22923335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor-Model for End-Stage Liver Disease and donor-recipient matching in liver transplantation.
    Vitale A; Ramirez Morales R; dalla Bona E; Scopelliti M; Zanus G; Neri D; d'Amico F; Gringeri E; Russo F; Burra P; Angeli P; Cillo U
    Transplant Proc; 2011 May; 43(4):974-6. PubMed ID: 21620029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C disease severity in living versus deceased donor liver transplant recipients: an extended observation study.
    Terrault NA; Stravitz RT; Lok AS; Everson GT; Brown RS; Kulik LM; Olthoff KM; Saab S; Adeyi O; Argo CK; Everhart JE; Rodrigo del R;
    Hepatology; 2014 Apr; 59(4):1311-9. PubMed ID: 24677192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyzing predictors of graft survival in patients undergoing liver transplantation with donors aged 70 years and over.
    Caso-Maestro O; Jiménez-Romero C; Justo-Alonso I; Calvo-Pulido J; Lora-Pablos D; Marcacuzco-Quinto A; Cambra-Molero F; García-Sesma A; Pérez-Flecha M; Muñoz-Arce C; Loinaz-Segurola C; Manrique-Municio A
    World J Gastroenterol; 2018 Dec; 24(47):5391-5402. PubMed ID: 30598583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varying Utilization Rates but Superior Outcomes in Liver Transplantation From Hepatitis C-positive Donors in the United States: An Analysis of the OPTN/UNOS Database.
    Bekki Y; Crismale JF; Myers B; Schiano TD; Florman S
    Transplantation; 2022 Sep; 106(9):1787-1798. PubMed ID: 35507448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the liver match study.
    Angelico M; Nardi A; Romagnoli R; Marianelli T; Corradini SG; Tandoi F; Gavrila C; Salizzoni M; Pinna AD; Cillo U; Gridelli B; De Carlis LG; Colledan M; Gerunda GE; Costa AN; Strazzabosco M;
    Dig Liver Dis; 2014 Apr; 46(4):340-7. PubMed ID: 24411484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor risk factors in orthotopic liver transplant: analysis of the OPTN/UNOS registry.
    Kawakita S; Everly MJ
    Clin Transpl; 2013; ():13-22. PubMed ID: 25095488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving National Results in Liver Transplantation Using Grafts From Donation After Cardiac Death Donors.
    Croome KP; Lee DD; Keaveny AP; Taner CB
    Transplantation; 2016 Dec; 100(12):2640-2647. PubMed ID: 27861295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.